Listar por tema "Reaproveitamento de drogas"

Fale com a Fiocruz

Fundação Oswaldo Cruz

Mostrando ítems 1-9 de 9

Atazanavir Is a Competitive Inhibitor of SARS-CoV-2Mpro, Impairing Variants Replication In Vitro and In Vivo

Chaves, Otávio Augusto et al. | Fecha del documento: 2022
Disulfiram repurposing in the combined chemotherapy of Chagas disease A protocol for phase I/II clinical trial

Saraiva, Roberto Magalhães et al. | Fecha del documento: 2021
Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase

Castilho, Vanessa V. S. et al. | Fecha del documento: 2018
Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy

Silva, M. R. Simões et al. | Fecha del documento: 2017
Identification of Hypericin as a Candidate Repurposed Therapeutic Agent for COVID-19 and Its Potential Anti-SARS-CoV-2 Activity

Matos, Aline da Rocha et al. | Fecha del documento: 2022
New drug candidates for osteosarcoma: Drug repurposing based on gene expression signature

Andrade, Raissa Coelho et al. | Fecha del documento: 2021
Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors

Sangenito, Leandro Stefano et al. | Fecha del documento: 2022
The pulmonary route as a way to drug repositioning in COVID-19 therapy

Sarcinelli, MIchelle Alvares et al. | Fecha del documento: 2021
Unveiling the Kinomes of Leishmania infantum and L. braziliensis Empowers the Discovery of New Kinase Targets and Antileishmanial Compounds

Borba, Joyce Villa Verde Bastos et al. | Fecha del documento: 2019